SQZ Bio (SQZ) Stock Forecast, Price Target & Predictions
SQZ Stock Forecast
SQZ Bio stock forecast is as follows: an average price target of $400.00 (represents a 786836.85% upside from SQZ’s last price of $0.05) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
SQZ Price Target
The average price target for SQZ Bio (SQZ) is $400.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $400.00 to $400.00. This represents a potential 786836.85% upside from SQZ's last price of $0.05.
SQZ Analyst Ratings
According to 1 Wall Street analysts, SQZ Bio's rating consensus is 'Buy'. The analyst rating breakdown for SQZ stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
SQZ Bio Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Dec 01, 2022 | - | Chardan Capital | $400.00 | $182.02 | 119.76% | 786836.85% |
The latest SQZ Bio stock forecast, released on Dec 01, 2022 by Chardan Capital company, set a price target of $400.00, which represents a 119.76% increase from the stock price at the time of the forecast ($182.02), and a 786836.85% increase from SQZ last price ($0.05).
SQZ Bio Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $0.05 | $0.05 | $0.05 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of SQZ Bio stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to SQZ Bio's last price of $0.05. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Dec 01, 2022 | Chardan Capital | Buy | Buy | Hold |
SQZ Bio's last stock rating was published by Chardan Capital on Dec 01, 2022. The company gave SQZ a "Buy" rating, the same as its previous rate.
SQZ Bio Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| SQZ | SQZ Bio | $0.44 | $400.00 | 90809.09% | Buy |
| KZR | Kezar Life Sciences | $0.57 | $17.50 | 2970.18% | Buy |
| PMVP | PMV Pharmaceuticals | $1.51 | $24.75 | 1539.07% | Buy |
| ANTX | AN2 Therapeutics | $1.04 | $8.75 | 741.35% | Buy |
| PCSA | Processa Pharmaceuticals | $1.34 | $9.00 | 571.64% | Buy |
| HOWL | Werewolf Therapeutics | $2.34 | $12.00 | 412.82% | Buy |
| LIPO | Lipella Pharmaceuticals | $0.40 | $2.00 | 400.00% | - |
| ANEB | Anebulo Pharmaceuticals | $2.08 | $6.00 | 188.46% | Buy |
| FENC | Fennec Pharmaceuticals | $5.47 | $15.75 | 187.93% | Buy |
| NUVB | Nuvation Bio | $3.05 | $7.00 | 129.51% | Buy |
| SABS | SAB Biotherapeutics | $2.79 | $5.67 | 103.23% | Buy |
| THRD | Third Harmonic Bio | $13.57 | $16.15 | 19.01% | Buy |
SQZ Forecast FAQ
Is SQZ Bio a good buy?
Yes, according to 1 Wall Street analysts, SQZ Bio (SQZ) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of SQZ's total ratings.
What is SQZ's price target?
SQZ Bio (SQZ) average price target is $400 with a range of $400 to $400, implying a 786836.85% from its last price of $0.0508. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will SQZ Bio stock go up soon?
According to Wall Street analysts' prediction for SQZ stock, the company can go up by 786836.85% (from the last price of $0.0508 to the average price target of $400), up by 786836.85% based on the highest stock price target, and up by 786836.85% based on the lowest stock price target.
Can SQZ Bio stock reach $0?
SQZ's average twelve months analyst stock price target of $400 supports the claim that SQZ Bio can reach $0 in the near future.